feed,title,long_url,short_url
Investors,Biohaven Plunges On A Surprise FDA Twist For Its Rare-Disease Drug,https://www.investors.com/news/technology/biohaven-stock-delay-troriluzole-sca/,https://da.gd/zMBuIe
